Perth, Australia – 24 September 2019: SUDA Pharmaceuticals Limited (ASX: SUD), a leader in oro-mucosal drug delivery, advises that Managing Director and Chief Executive Officer, Mr Stephen Carter, has resigned effective 23 September after nearly nine years on the board and management team.
Non-executive Chairman, Mr Paul Hopper, has been appointed Executive Chairman in the interim until a permanent CEO replacement is identified.
For further information please download the attached PDF:
Download this document
